European Reference Laboratory for Class D in vitro diagnostic medical devices (EURL-IVD) in the categories: (I) Detection and quantification of bacterial infection markers (Treponema pallidum) and (II) detection and quantification of herpesvirus infection markers (Citomegalovirus and Epstein-Barr Virus).
On December 5, 2023, the European Commission published (Regulation (EU) 2023/2713) the designation of 5 laboratories in Europe as European Reference Laboratories (EURL) for high-risk in vitro diagnostic medical devices (IVDs) (Class D). These EURLs have been selected based on the criteria established in the Implementing Regulation (EU) 2022/944.
The consortium formed by the Medical Microbiology Departments of three hospitals belonging to the Madrid Health Service (SERMAS) has been one of the designated entities, these being Hospital Universitario La Paz, Hospital Universitario Ramón y Cajal and Hospital General Universitario Gregorio Marañón.